Buzzi Unicem : Report on the purchase of treasury shares
October 29, 2018 at 08:07 pm IST
Share
October 29, 2018
Buzzi Unicem SpA announces that during the period from October 22, 2018 through October 26, 2018 it acquired no. 593,000 ordinary treasury shares for a total consideration of 9,483,199.10 Euro, as authorized by the Ordinary General Meeting on May 10, 2018.
Details of the daily transactions on the Mercato Telematico Azionario are as follows:
Date
Number of ordinary
shares purchased
Average price
(Euro)
Consideration
(Euro)
10/22/2018
270,000
16.1765
4,367,655.00
10/24/2018
150,000
15.8887
2,383,305.00
10/25/2018
73,000
15.8867
1,159,729.10
10/26/2018
100,000
15.7251
1,572,510.00
Total
593,000
15.9919
9,483,199.10
Attached to this press release is a daily recap of the purchase transactions carried out during the reference period.
Following the above purchases, the Company holds no. 3,678,000 ordinary shares and no. 29,290 saving shares as of October 26, 2018, equal to 1.80% of the issued share capital.
Buzzi Unicem S.p.A. published this content on 29 October 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 29 October 2018 14:36:11 UTC
Buzzi SpA, formerly known as Buzzi Unicem SpA, is an Italy-based company engaged in the manufacture of construction materials. The Company is primarily active in the production, distribution, and sale of cement, ready-mix concrete, and natural aggregates. The Companyâs operations are located in Italy, the United States, Germany, Luxembourg and the Netherlands, Poland, the Czech Republic and Slovakia, Ukraine, Russia, Mexico, Brazil, and Algeria. The three main geographical area with the higher generation of revenues are: the United States, Germany, and Mexico. The Firm is also engaged in the activity of Research and Development with the aim of developing and experimenting innovations to be used in the production chain and for their products. This activity is performed in cooperation with national research centers, universities, and private laboratories.